Jackson Wong PhD

Jackson is a core part of the editorial team at GoodMoneyGuide.com. With over 15 years industry experience as a financial analyst, he brings a wealth of knowledge and expertise to our content and readers. Previously Jackson was the director of Stockcube Research as Head of Investors Intelligence. This pivotal role involved providing market timing advice and research to some of the world's largest institutions and hedge funds. Jackson brings a huge amount of expertise in areas as diverse as global macroeconomic investment strategy, statistical backtesting, asset allocation, and cross-asset research. Jackson has a PhD in Finance from Durham University and has authored nearly 200 articles for GoodMoneyGuide.com.

Avacta

Avacta shares are approaching 6 month highs, are they still a buy?

Avacta Life Sciences Group Plc (www.avacta.com) is a small-cap biotech company. Two key divisions support the health company: Oncology drug development (Therapeutics) and Diagnostics. The latter is about expanding the in-vitro diagnostics business to support the medical profession; while the former is about leveraging its proprietary pre|CISION and Affirmer platforms to develop cancer therapies. What makes Avacta …

Avacta shares are approaching 6 month highs, are they still a buy? Read More »

Scroll to Top